Literature DB >> 2285061

Surgical and nonsurgical complications associated with cochlear prosthesis implantation.

I M Windmill1, S A Martinez, M B Nolph, B A Eisenmenger.   

Abstract

Relatively few complications have been reported for cochlear implant surgery in spite of a recent report detailing a complication rate of 11.8 percent. This report highlights both the surgical and nonsurgical complications we have encountered that have resulted in either replacement of the implanted prosthesis or compromise of the sound processing strategy employed by the external unit. These complications make a strong argument for the use of preoperative, intraoperative, and postoperative radiologic examinations. Since the complications reported herein have not been attributed to the implant device proper, we feel cochlear implantation remains a safe and effective procedure for those patients who are untreatable by traditional methods.

Entities:  

Mesh:

Year:  1990        PMID: 2285061

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  4 in total

1.  Relationship of cochlea with surrounding neurovascular structures and their implication in cochlear implantation.

Authors:  Daisy Sahni; Anjali Singla; Ashok Gupta; Tulika Gupta; Anjali Aggarwal
Journal:  Surg Radiol Anat       Date:  2015-02-08       Impact factor: 1.246

2.  Cochlear implant electrode misplacement: incidence, evaluation, and management.

Authors:  Yu-Lan Mary Ying; Jerry W Lin; John S Oghalai; Robert A Williamson
Journal:  Laryngoscope       Date:  2013-01-08       Impact factor: 3.325

3.  Revision surgeries in cochlear implant patients: a review of 45 cases.

Authors:  Lela Migirov; Riki Taitelbaum-Swead; Minka Hildesheimer; Jona Kronenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-29       Impact factor: 2.503

4.  Clinical outcomes of cochlear reimplantation due to device failure.

Authors:  Chong-Sun Kim; Dong-Kyu Kim; Myung-Whan Suh; Seung Ha Oh; Sun O Chang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-03-20       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.